Is it time for individualized thromboprophylaxis regimens in the ICU?

Affiliations

Editorial

Ian Welsby et al. Crit Care Med. 2015 Feb.

. 2015 Feb;43(2):500-1.

doi: 10.1097/CCM.0000000000000784.

¹ Department of Anesthesiology, Duke University Medical Center, Durham, NC Department of Medicine, Duke University Medical Center, Durham, NC.

No abstract available

Comment on

Failure of anticoagulant thromboprophylaxis: risk factors in medical-surgical critically ill patients*.
Lim W, Meade M, Lauzier F, Zarychanski R, Mehta S, Lamontagne F, Dodek P, McIntyre L, Hall R, Heels-Ansdell D, Fowler R, Pai M, Guyatt G, Crowther MA, Warkentin TE, Devereaux PJ, Walter SD, Muscedere J, Herridge M, Turgeon AF, Geerts W, Finfer S, Jacka M, Berwanger O, Ostermann M, Qushmaq I, Friedrich JO, Cook DJ; PROphylaxis for ThromboEmbolism in Critical Care Trial Investigators. Lim W, et al. Crit Care Med. 2015 Feb;43(2):401-10. doi: 10.1097/CCM.0000000000000713. Crit Care Med. 2015. PMID: 25474533 Clinical Trial.